Ardana Plc (ARA.L)
6.50GBp
17 Feb 2009
0.00p (+0.00%)
6.50p
--
0.00p
0.00p
20,000
0
6.50p
6.50p
ARA.L
About
Overall
| Beta: | 0.21 |
| Market Cap (Mil.): | £4.26 |
| Shares Outstanding (Mil.): | 65.50 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| ARA.L | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 6.43 | 3.76 |
| EPS (TTM): | -8.23 | -- | -- |
| ROI: | -110.70 | 5.95 | 2.30 |
| ROE: | -110.70 | 8.98 | 2.82 |
Consolidation may immunise biotech investors
LONDON (Reuters) - After seeing the value of investments tumble in the credit crisis, an emerging trend of industry consolidation in the UK biotech sector could be a welcome shot in the arm for investors.
Biotech Ardana folds as fails to find buyer
LONDON (Reuters) - Scotland's Ardana has gone into voluntary administration after failing to refinance the business or find a buyer, underlining the tough environment facing many small British biotech companies.
INTERVIEW-ProStrakan Looks to Quadruple Sales
(Adds further CEO, analyst comment, detail, updates shares)
Alltracel Agrees 20.8 Mln Stg Takeover
LONDON (Reuters) - Irish healthcare group Alltracel became the latest in a string of biotech companies to admit to a funding crisis on Friday, agreeing a 20.8 million pound ($40.86 million) takeover by U.S. firm HemCon.
Alltracel Agrees 20.8 Mln Stg Takeover
LONDON (Reuters) - Irish healthcare group Alltracel became the latest in a string of biotech companies to admit to a funding crisis on Friday, agreeing a 20.8 million pound ($40.86 million) takeover by U.S. firm HemCon.
UPDATE 1-Cashed-up Antisoma looks for biotech acquisitions
LONDON, Feb 21 (Reuters) - British biotechnology firm Antisoma is looking to buy other cancer drug developers struggling for funding in the current credit crisis, Chief Executive Glyn Edwards said on Thursday.
Newspaper round-up
(Reuters) - Pendragon, Anglo American and SABMiller feature in our round-up of Thursday's business press.
Newspaper round-up
(Reuters) - Centrica, Cadbury and Tesco feature in our round-up of Wednesday's business press.
Earnings vs 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
